Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

French drug trial disaster leaves one brain dead, five injured

One person has been left brain dead and five others are in a serious condition after taking part in a clinical trial in France of an experimental medicine from an unnamed drug company, the French Health Ministry said on Friday. The ministry did not say what the medicine was intended to be used for. A […]

Read More »

FDA clears Olympus duodenoscope with design modifications

The U.S. Food and Drug Administration on Friday cleared Japan’s Olympus Corp’s duodenoscope with changes to the device’s design and labeling intended to help reduce the risk of bacterial infections. Olympus will voluntarily recall its original model being used in health care facilities to fix them as quickly as possible, the regulator said. ( The […]

Read More »

Drug shortages in U.S. emergency rooms on the rise

(Reuters Health) – U.S. emergency rooms are increasingly running short on medications, including many that are needed for life-threatening conditions, a recent study documents. Since 2008, the number of shortages has risen by more than 400 percent, researchers found. Half of all emergency room shortages were for life-saving drugs, and for one in 10 there […]

Read More »

Theracos Snags $25 Million for Diabetes Drug

MARLBOROUGH, Mass. – Privately-held Theracos, Inc. raised $25 million to fund development of bexagliflozin, an experimental SGLT-2 inhibitor for the treatment of Type 2 diabetes, MedCityNews reported this morning. SGLT2 is an acronym for sodium-glucose linked transporter 2, a membrane protein that acts as a portal for glucose into the cell. SGLT2 inhibitors have been […]

Read More »

Merck Resolves Previously Disclosed Securities Class Action Lawsuit Related to Vioxx

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that it has reached an agreement with plaintiffs to resolve In re Merck & Co., Inc. Securities Litigation, a multi-district class action lawsuit pending in New Jersey federal court. The settlement class consists of persons who purchased Merck securities during […]

Read More »

Heron Therapeutics Notified by FDA That It Will Not Take Action on SUSTOL New Drug Application by the PDUFA Date

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Heron Therapeutics, Inc. (NASDAQ:HRTX), announced today that the U.S. Food and Drug Administration (FDA) has informed the Company that it has not yet completed its review of the New Drug Application (NDA) of SUSTOL® (granisetron) Injection, extended release and would not be taking action by the Prescription Drug User Fee Act (PDUFA) […]

Read More »

Sanofi Pasteur Provides Key Support to the Human Vaccines Project

The research program is designed to accelerate the development of vaccines by decoding the human immune system

Read More »

Liberia declared Ebola-free, signaling end to West African epidemic

Liberia was declared free of the Ebola virus by global health experts on Thursday, a milestone that signaled an end to an epidemic in West Africa that has killed more than 11,300 people. But the World Health Organisation (WHO) warned there could still be flare-ups of the disease in the region, which has suffered the […]

Read More »

FDA rejects BioMarin’s DMD drug

BioMarin Pharmaceutical Inc said on Thursday the U.S. Food and Drug Administration had rejected the company’s drug to treat a rare muscle-wasting disorder. The rejection caps months of uncertainty surrounding the drug, Kyndrisa, which was billed to be the first treatment in the United States for Duchenne muscular dystrophy. DMD, which affects one in 3,600 […]

Read More »

Apple Ramps Up its Medtech Workforce

SAN FRANCISCO – Apple (AAPL) is continuing to make moves in its healthcare division, developing wearable gear and hiring four new positions in its health technology division, including listings for biomedical engineers and a lab technician, BuzzFeed reported on Tuesday. The new positions are likely to support Apple’s continued foray into developing wearable medical devices. […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom